May 25, 2017
1:10
For every 10 shares held, investors received 1. The price per share adjusted from $0.78 to $0.08.
The split itself did not change the total investment value.
Avivagen Inc. (VIVXF) trades on the Other OTC in the Drug Manufacturers - Specialty & Generic industry.
Avivagen Inc. company overviewThe latest split shown was on May 25, 2017. It was a 1-for-10 reverse split, so shareholders received 1 share for every 10 they held.
This history records one reverse split, on May 25, 2017.
Already premium?